[Diagnostic and therapeutic aspects of neuroleptic malignant syndrome based on 12 cases].
Sczesni
B
B
Neurologische Klinik, Ruhr-Universität, Bochum, Bundesrepublik Deutschland.
Becker
H
H
Schröder
J
J
Bittkau
S
S
von Baumgarten
F
F
Truong
D D
DD
Przuntek
H
H
D000328:Adult; D000547:Amantadine / Q000008:administration & dosage; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001971:Bromocriptine / Q000008:administration & dosage; D003620:Dantrolene / Q000008:administration & dosage; D003866:Depressive Disorder / Q000188:drug therapy*; D003975:Diazepam / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008607:Intellectual Disability / Q000188:drug therapy*; D008090:Lisuride / Q000008:administration & dosage; D008297:Male; D008875:Middle Aged; D009459:Neuroleptic Malignant Syndrome / Q000175:diagnosis* / Q000188:drug therapy; D011618:Psychotic Disorders / Q000188:drug therapy*; D012559:Schizophrenia / Q000188:drug therapy*
D014150:Antipsychotic Agents; D001971:Bromocriptine; D000547:Amantadine; D008090:Lisuride; D003620:Dantrolene; D003975:Diazepam
Diagnostische und therapeutische Aspekte des neuroleptischen malignen Syndroms anhand von 12 Fällen.